Patent Assignment
Reel/Frame 029767/0524
Release of Security Interest
Recorded: 2013-02-06
Pages: 11
Assignors
AYER CAPITAL PARTNERS MASTER FUND, L.P.
Executed: 2013-02-05
MPM BIOVENTURES III, L.P.
Executed: 2013-01-24
MPM BIOVENTURES III-QP, L.P.
Executed: 2013-01-24
MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
Executed: 2013-01-24
MPM BIOVENTURES III PARALLEL FUND, L.P.
Executed: 2013-01-24
AYER CAPITAL PARTNERS KESTREL FUND, L.P.
Executed: 2013-02-05
MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC
Executed: 2013-01-24
Assignee
ARYX THERAPEUTICS, INC.
6300 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Properties
(31)
Novel Compound for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Patent:
5,364,880 →
Application:
08/078,371 →
Novel Compound for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Patent:
5,440,054 →
Application:
08/260,869 →
Novel Compound for Treatment of Cardiac Arphythmia, Synthesis, and Methods of Use
Patent:
5,849,788 →
Application:
08/468,602 →
Novel Compound for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Patent:
6,130,240 →
Application:
09/211,246 →
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent:
6,372,783 →
Application:
09/680,873 →
Novel compounds for treatment of cardiac arrhythmia synthesis, and methods of use
Patent:
6,316,487 →
Application:
09/680,880 →
Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
Patent:
6,362,223 →
Application:
09/684,046 →
Materials and Methods for the Treatment of Gastroesophageal Reflux Disease
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Materials and Methods for Treating Coagulation Disorders
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Novel Enantiomeric Compounds for Treatment of Cardiac Arrhythmias and Methods of Use
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Materials and Methods for Treating Coagulation Disorders
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Novel Compounds for Treatment of Cardiac Arrhythmia, Synthesis, and Methods of Use
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Materials and Methods for Treating Coagulation Disorders
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Antiarrhythmic Precursor Compounds, Methods of Synthesis and Methods of Use
Materials and Methods for Treating Coagulation Disorders
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Stereoisomeric Compounds and Methods for the Treatment of Gastrointestinal and Central Nervous System Disorders
Haloalkyl Ester Derivatives of Coumarin for the Treatment of Coagulation Disorders
Novel Compounds For Treatment of Cardiac Arrhythmia and Methods of Use
Application:
11/936,620 →
Publication:
US 2008/0114059
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders
Halogenated Ester Derivatives of Coumarins for the Treatment of Coagulation Disorders
Methods for Treating Atrial Fibrillation and Reducing Stroke Rate in Atrial Fibrillation Patients
Application:
61/263,465 →
Methods for Stroke Reduction in Atrial Fibrillation Patients
Application:
61/263,564 →
Methods for Treating Atrial Fibrillation
Application:
61/263,567 →
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 025006 Frame 0740. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc.
May 31, 2012
From: DRUZGALA, PASCAL; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028307/0394 →
Assignment of Assignor's Interest
Jun 20, 2012
From: DRUZGALA, PASCAL; ZHANG, XIAOMING; PFISTER, JURG
To: ARYX THERAPEUTICS
Reel/Frame 028411/0068 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016464 Frame 0278. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc..
Aug 31, 2012
From: IRWIN, IAN; PALME, MONICA; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028890/0001 →
Assignment of Assignor's Interest
Sep 4, 2012
From: IRWIN, IAN; PALME, MONICA; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 028894/0453 →
Assignment of Assignor's Interest
Oct 4, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029080/0290 →
Assignment of Assignor's Interest
Oct 10, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029106/0435 →
Assignment of Assignor's Interest
Oct 10, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029105/0808 →
Corrective Assignment to Correct the the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016757 Frame 0545. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics. the Assignee Name Should Not Have Had Inc..
Oct 10, 2012
From: IRWIN, IAN; PALME, MONICA; BECKER, CYRUS
To: ARYX THERAPEUTICS
Reel/Frame 029109/0542 →
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016571 Frame 0719. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics Without the Inc.
Oct 16, 2012
From: DRUZGALA, PASCAL
To: ARYX THERAPEUTICS
Reel/Frame 029136/0086 →
Change of Name
Oct 17, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029148/0007 →
Assignment of Assignor's Interest
Oct 22, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029169/0137 →
Correction of Assignors, Peter G. Milner Was Accidently Omitted, When Assignment Previously Recorded at Reel/Frame 029105/0808
Oct 26, 2012
From: DRUZGALA, PASCAL; MILNER, PETER G.
To: ARYX THERAPEUTICS
Reel/Frame 029201/0099 →
Assignment of Assignor's Interest
Jul 17, 2013
From: DRUZGALA, PASCAL J.
To: ARMETHEON, INC.
Reel/Frame 030816/0442 →
Change of Name
Dec 9, 2016
From: NARONAPRIDE, LLC
To: RENEXXION, LLC
Reel/Frame 040876/0342 →
Assignment of Assignor's Interest
Dec 9, 2016
From: ARMETHEON, INC.
To: NARONAPRIDE, LLC
Reel/Frame 040699/0559 →
Security Interest
Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name
Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest
Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →
Assignment of Assignor's Interest
May 4, 2022
From: HESP LLC
To: CADRENAL THERAPEUTICS
Reel/Frame 059811/0221 →
Release of Security Interest
Oct 4, 2022
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: ESPERO BIOPHARMA, INC.
Reel/Frame 061299/0927 →